Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report

doi:10.12998/wjcc.v10.i18.6184

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3232)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

208

WORD

132

HTML

1701

Figures (1-3)

191

Tables (1-1)

198

Sum=2430

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

264

Download

538

Sum=802

Jun 26, 2022 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jun 26, 2022; 10(18): 6184-6191
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6184

Full Size Figure Download Figure

Figure 1 Histology and immunohistochemistry images. A: Histology; B: Positivity for programmed death-ligand 1 (combined positive score = 1); C: Positivity for human epidermal growth factor receptor 2.

Citation: Liu R, Wang X, Ji Z, Deng T, Li HL, Zhang YH, Yang YC, Ge SH, Zhang L, Bai M, Ning T, Ba Y. Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report. World J Clin Cases 2022; 10(18): 6184-6191
URL: https://www.wjgnet.com/2307-8960/full/v10/i18/6184.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i18.6184